ARTIN BIOSCIENCE

Committed to Respiratory Therapies and Allergies

Artin Bioscience's mission is to develop and provide therapies for respiratory diseases and immune system allergic reactions.  Our lead indications being Chronic Obstructive Pulmonary Disease (COPD), and Pulmonary Arterial Hypertension (PAH) and Peanut Allergy. The drug therapies we are developing have applications to other diseases such as Interstitial Lung Disease, Covid 19, Asthma, ARDS and others. Our focus at this time is to complete phase 1 and 2 drug trials for COPD, PAH and Peanut Allergy